Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

ORIC Pharmaceuticals, Inc. ORIC

Set alert

Price alert · ORIC

All alert types
9.70 USD +0.63 +6.95%

As of Nov 3, 1:12 PM ET

Bid
9.70 × 2
Ask
9.73 × 2
9.17 Day range 9.94
7.47 52-week range 14.65
YTD
+18.58%
1 year
-23.56%
Open
9.17
Prev close
9.07
Mkt cap
1.01B
Vol
855.82K
Avg vol
1.58M
EPS
-1.32
P/E
0.00
Div yield
0.00%
More statistics
Low
9.17
High
9.94
Forward P/E
-7.87
Beta
0.98
Short ratio
11.16
Inst. own
123.41%
Dividend
0.00
Ex-div date
Earnings
Nov 12, 2026
50-d avg
12.96
200-d avg
11.13
1y target
21.64

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 10, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Sep 23, 2026Rating: BTIG · — → Buy
  • Oct 5, 2026Rating: Leerink Partners · — → Outperform
  • Oct 14, 2026Rating: JP Morgan · Overweight → Overweight
Signals (26)
NameDateAgo
SMA: BearishOct 26, 20261 week ago
SMA: BearishOct 26, 20261 week ago
MACD: Sell SignalOct 26, 20261 week ago
RSI: OversoldOct 26, 20261 week ago
SMA: BullishOct 20, 20262 weeks ago
SMA: BullishOct 19, 20262 weeks ago
MACD: Buy SignalOct 19, 20262 weeks ago
SMA: BearishOct 16, 20262 weeks ago
SMA: BullishOct 15, 20262 weeks ago
MACD: Sell SignalOct 2, 20261 month ago
SMA: BearishOct 1, 20261 month ago
SMA: BearishOct 1, 20261 month ago
SMA: BullishSep 28, 20261 month ago
SMA: BullishSep 22, 20261 month ago
MACD: Buy SignalSep 22, 20261 month ago
SMA: BullishSep 16, 20261 month ago
SMA: BearishSep 15, 20261 month ago
SMA: BullishSep 14, 20261 month ago
SMA: BearishSep 10, 20261 month ago
SMA: BearishSep 3, 20262 months ago

Newest 20 of 26.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 21.64 +123.1% upside
Target (low)
14.00
Target (mean)
21.64
Target (high)
27.00
Ratings (0m) 16 15 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy13
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 16
  • 1 month ago 15
  • 2 months ago 14
  • 3 months ago 15

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ORIC analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.37887-0.45 – -0.32-0.33-14.8%00.0%13
Next quarter-0.39578-0.47 – -0.33713-0.30-31.9%00.0%13
Current year-1.49-1.64 – -1.25-1.47-1.3%00.0%13
Next year-1.67-1.91 – -1.37-1.49-12.4%00.0%13

Upgrades and downgrades

The latest rating changes

ORIC analyst upgrades and downgrades
DateFirmActionFromTo
Oct 14, 2026JP MorganMaintainedOverweightOverweight
Oct 5, 2026Leerink PartnersInitiated—Outperform
Sep 23, 2026BTIGInitiated—Buy
Aug 10, 2026HC Wainwright & Co.MaintainedBuyBuy
Jun 8, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 15, 2026Goldman SachsUpgrade—Buy
May 5, 2026CitigroupMaintainedBuyBuy
Apr 2, 2026HC Wainwright & Co.ReiteratedBuyBuy
Apr 1, 2026WedbushMaintainedOutperformOutperform
Mar 13, 2026HC Wainwright & Co.ReiteratedBuyBuy
Feb 24, 2026CitigroupMaintainedBuyBuy
Feb 24, 2026HC Wainwright & Co.MaintainedBuyBuy
Feb 24, 2026WedbushReiteratedOutperformOutperform
Jan 13, 2026WedbushReiteratedOutperformOutperform
Jan 7, 2026Piper SandlerInitiated—Overweight
Dec 8, 2025Wells FargoMaintainedOverweightOverweight
Dec 8, 2025WedbushReiteratedOutperformOutperform
Nov 20, 2025Evercore ISI GroupInitiated—Outperform
Nov 18, 2025Wolfe ResearchInitiated—Peer Perform
Nov 18, 2025JP MorganMaintainedOverweightOverweight
Nov 17, 2025CitigroupMaintainedBuyBuy
Nov 14, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 14, 2025Wells FargoMaintainedOverweightOverweight
Nov 14, 2025OppenheimerMaintainedOutperformOutperform
Aug 14, 2025JP MorganMaintainedOverweightOverweight
Aug 14, 2025HC Wainwright & Co.MaintainedBuyBuy
Aug 13, 2025GuggenheimReiteratedBuyBuy
Jul 8, 2025Ladenburg ThalmannInitiated—Buy
May 19, 2025JP MorganMaintainedOverweightOverweight
May 9, 2025HC Wainwright & Co.MaintainedBuyBuy